Table 2.
Baseline Characteristics of Patients (n=42)
| Placebo N (%) | Steroid N (%) | P-value | |
|---|---|---|---|
| Age (mean years ± SD) | 44.1 ± 17.0 | 49.9 ± 13.0 | 0.22* | 
| Sex | |||
| Male | 11 (50.0) | 11 (55.0) | 0.75** | 
| Female | 11 (50.0) | 9 (45.0) | |
| Organisms | |||
| Coagulase-neg Staphylococcus | 3 (13.64) | 2 (9.52) | |
| Diphtheroids | - | 1 (4.76) | |
| Staphylococcus aureus | 2 (9.09) | - | |
| Streptococcus pneumoniae | 10 (45.45) | 9 (42.86) | |
| Viridans-group Streptococcus spp | 1 (4.55) | 3 (14.29) | 0.51** | 
| Haemophilus influenzae | - | 1 (4.76) | |
| Moraxella spp | 1 (4.55) | - | |
| Pseudomonas spp (non-aeruginosa) | - | 1 (4.76) | |
| Pseudomonas aeruginosa | 4 (18.18) | 4 (19.05) | |
| Aeromonas hydophila | 1 (4.55) | - | |
| Mean enrollment visual acuity (logMAR ± SD) | 1.15 ± 0.63 | 1.28 ± 0.54 | 0.50* | 
| Mean enrollment infiltrate/scar diameter (mm ± SD) | 1.8 ± 1.6 | 2.0 ± 1.2 | 0.63* | 
Independent sample t-test
Fisher’s exact test